PRMT1 and chronic obstructive pulmonary disease: Conversely, PRMT1 overexpression in ECs, achieved through transfection or AAV‐mediated viral transduction in a COPD model, reduced EC dysfunction and suppressed NF‐κB activation, thereby attenuating inflammation and alleviating the COPD phenotype.